Advanced Search

 

Study ID Status Title Patient Level Data
114885 Completed A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
114886 Terminated Safety and immunogenicity study of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 when administered to adults with TB disease
114907 Recruiting Continuous Access to advanced and metastatic renal cell Carcinoma therapy with Everolimus post pazopanib treatment
114910 Completed A study on the impact of rotavirus vaccination on hospitalisations for rotavirus gastroenteritis in children aged <5 years in Australia
114915 Active not recruiting A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each administered with fixed-dose dual nucleoside reverse transcriptase inhibitor therapy over 96 weeks in HIV-1 infected antiretroviral naïve adult subjects
114916 Recruiting A Dolutegravir Open Label Protocol for HIV infected, Adult and Adolescent Patients with Integrase Resistance
114917 Completed Assessment of safety of GlaxoSmithKline (GSK) Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine, Infanrix-IPV when administered according to the approved Prescribing Information in Korea
114919 Completed An open-label, randomised, crossover study to assess the relative bioavailability of different 2mg formulations of GSK2018682(S1P1 agonist) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114922 Completed A randomized cross-over study to evaluate the pharmacokinetics and pharmacodynamics of twice daily oral administration of GSK1325756, compared to placebo, in healthy subjects; and the pharmacokinetic profile of twice daily oral administration of GSK1325756 in healthy fed and fasted elderly subjects Study Listed on ClinicalStudyDataRequest.com
114926 Completed An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects
114930 Completed DB2114930: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
114937 Completed Burden of Frequent and Infrequent Exacerbating Patients with Chronic Obstructive Pulmonary Disease (COPD)
114940 Active not recruiting USHO-11-3281: Predictors of stepping down asthma therapy: observational study and Fluticasone propionate-Salmeterol Combination Therapy outcomes study
114941 Active not recruiting Assessment of asthma-related resources after initiation of an inhaled corticosteroid switch: Observational study
114951 Completed DB2114951: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
114955 Completed Retrospective Administrative Claims Database Evaluation of Utilization of Belimumab in United States Managed Care Settings
114956 Completed A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
114957 Completed A Randomized, Open-label, Single-dose, Two-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of lamivudine and adefovir dipivoxil (100mg/10mg) to Heptodin® (100mg ) and Hepsera® (10mg)
114968 Completed A Three-part Study of Eltrombopag in Thrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: open-label, Part 2: randomized, double-blind, Part 3: extension)
114971 Recruiting Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg once daily on Growth Velocity in Prepubertal, Paediatric Subjects with Asthma
114974 Completed A randomised, double blind placebo controlled, 2 way cross over study in adults with non-allergic rhinits to evaluate the effect of once daily administration of intranasal SB-705498 12mg for two weeks and the response to a chamber challenge of cold dry air Study Listed on ClinicalStudyDataRequest.com
114985 Completed A first time in human, single blind, randomized, placebo-controlled,dose escalating crossover study to evaluate the safety,tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114987 Terminated An open-label, phase 2a study to evaluate pazopanib eye drops administered for 12 weeks to patients with neovascular age-related macular degeneration
114989 Completed Neisseria meningitidis burden of disease
114991 Completed Neisseria meningitidis carriage study

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.